Archive · 8 Jan 2026

Hyderabad Firm Gets US Nod for Generic ADHD Drug

Hyderabad Firm Gets US Nod for Generic ADHD Drug

A company in Hyderabad, India, called Granules Pharmaceuticals, has gotten permission from the US government to sell a cheaper version of a medicine used to treat ADHD.

This medicine, called Amphetamine Extended-Release Tablets, is a copy of a more expensive drug called Dyanavel XR.

The US government has also said that Granules can be the only company selling this medicine for 180 days, which means they won't have competition for a while.

This is good news because it might make the medicine cheaper and easier to get for people who need it.

The company has also gotten permission to sell another ADHD medicine in the US.

Doctors use these medicines to help people with ADHD focus better and control their behavior.

But it's important to use these medicines carefully, as they can have side effects and should only be taken under a doctor's supervision.

Sources